How to Buy Cue Biopharma Stock
Cue Biopharma Inc
Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders.
Cue Biopharma stock last closed at $0.77, down 3.16% from the previous day, and has decreased 46.13% in one year. It has overperformed other stocks in the Biotechnology industry by 0.31 percentage points. Cue Biopharma stock is currently +70% from its 52-week low of $0.45, and -66.15% from its 52-week high of $2.26.
As of Apr 29, 2025, there are 61.82M shares of CUE outstanding. The market cap of CUE is $47.29M. In the last 24 hours, 88,763 CUE shares were traded.
How to Buy Cue Biopharma Stock
Not sure how to invest in Cue Biopharma stock? Here's how.
- Choose where to buy Cue Biopharma stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Cue Biopharma stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your payment method and add your details.
- Evaluate Cue Biopharma stock: The Cue Biopharma ticker symbol is CUE. Is Cue Biopharma stock a good investment? Should you buy shares of CUE? How do CUE's underlying business fundamentals look? Do top analysts think Cue Biopharma is a good buy? Why has CUE's stock price moved recently? (Hint: Our stock research website can help you decide if CUE is a good stock to buy).
- Place your CUE buy order: Decide if you will purchase CUE shares at the current market price or use a limit order to purchase CUE stock at a specific price.
- Watch your investment in CUE: Create a watchlist to monitor your position in Cue Biopharma shares.
Step 1: Choose where to buy Cue Biopharma stock
You need an online brokerage account to access the NASDAQ market and buy CUE shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in CUE stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've created your account on stock apps to use, you need to deposit funds:
Check out this video walkthrough if you need help transferring funds into your new brokerage account.
Step 4: Evaluate Cue Biopharma stock
Once you have selected the best place to buy Cue Biopharma stock, it's important to analyze their stock before you invest, so you truly wrap your head around the risk as well as the upside.
Cue Biopharma stock quick numbers
Cue Biopharma Overview
WallStreetZen was created to help everyday investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on CUE's stock page.
Is CUE stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge CUE's fair value.
Using relative valuations methods:
- CUE could be undervalued based on its P/B ratio of 2.7x, relative to Biotechnology industry P/B ratio of 4.37x
You can do more valuation research on CUE's stock here.
CUE Financial Overview
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the CUE balance sheet.
- There are more short-term assets than short-term liabilities on the CUE balance sheet.
- CUE has $22.61M in cash and short term investments. This is enough to cover its annual cash burn of $36.30M.
Negative Financial Indicators:
- CUE has cash burn of 36297000. It does not have enough cash and short-term investments to cover this.
- CUE profit margin has gone up by 4.86 percentage points in the past year, but the company is still unprofitable.
- Total CUE debt is higher than 5 years ago, relative to shareholder equity.
- CUE has a relatively high debt to equity ratio of 0.84.
Do analysts think it's a good time to buy CUE stock
Out of 1 Wall Street analysts who give ratings on CUE, the consensus analyst rating on Cue Biopharma is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Cue Biopharma stock forecast page.
CUE Momentum
How are CUE Revenues/Earnings doing?
Last year, CUE revenue was $9.29M. Over the last 5 year, CUE's revenue has increased by 21.84% per year. This was slower than the Biotechnology industry average of 45.47%.
You can research CUE's earnings and revenue performance here.
Who is buying/selling CUE?
In the last year, insiders at CUE have bought more shares than they have sold.
Daniel R. Passeri, CHIEF EXECUTIVE OFFICER of CUE, was the latest CUE insider to buy. They bought $30,900.00 worth of CUE stock on Dec 16, 2024.
Research more about who owns CUE stock here.
Does CUE provide a stable income stream?
No, Cue Biopharma doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your CUE buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, use a limit order.
Hit the Open Trade button and your broker will place your order.
If you require additional help with buying stocks on eToro, click the how to video below:
Step 6: Watch your investment in CUE
Now that you own some shares in CUE, you'll want to stay up-to-date on your shares.
Create a watchlist to keep track of your CUE stock.
CUE Feed
How to Buy Stock in Cue Biopharma
To reiterate, here are the 6 steps to buy Cue Biopharma stock:
- Choose where to buy Cue Biopharma stock
- Open your brokerage account
- Put funds into your investment account
- Evaluate Cue Biopharma stock
- Place your CUE buy order
- Watch your investment in CUE
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Cue Biopharma, add CUE to your watchlist by clicking the button below.
Other Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.